SUNITINIB PLIVA

Capsule, hard, 50 mg
RestrictedActive license

Active substance (INN)

sunitinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength50 mg
PackagingUkupno 28 kapsula tvrdih u blisteru djeljivom na pojedinačne doze (4x7) u kartonskoj kutiji
ManufacturerTeva Operations Poland Sp. z o.o., Poland
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateFebruary 13, 2023

Analogs in Montenegro

20

Other medicines with the same active substance

Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026